ClearPoint Neuro Management
Management criteria checks 3/4
ClearPoint Neuro's CEO is Joe Burnett, appointed in Nov 2017, has a tenure of 6.5 years. total yearly compensation is $2.00M, comprised of 25.9% salary and 74.1% bonuses, including company stock and options. directly owns 0.97% of the company’s shares, worth $1.43M. The average tenure of the management team and the board of directors is 3.2 years and 5.6 years respectively.
Key information
Joe Burnett
Chief executive officer
US$2.0m
Total compensation
| CEO salary percentage | 25.9% |
| CEO tenure | 6.5yrs |
| CEO ownership | 1.0% |
| Management average tenure | 3.2yrs |
| Board average tenure | 5.6yrs |
Recent management updates
Recent updates
ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19
Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Jan 19ClearPoint Neuro: Underlying Growth Potential Concealed By COVID
Jan 14ClearPoint Neuro: Becoming The Neurosurgical Platform Of Choice
Oct 01ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company
Aug 06Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?
Jul 19Clearpoint Neuro (CLPT) Investor Presentation - Slideshow
May 28Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation
May 27US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results
May 13ClearPoint Neuro partners with D&K Engineering
May 10ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Path To Profitability
Apr 16CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$518k | -US$22m |
| Sep 30 2023 | n/a | n/a | -US$22m |
| Jun 30 2023 | n/a | n/a | -US$21m |
| Mar 31 2023 | n/a | n/a | -US$18m |
| Dec 31 2022 | US$2m | US$494k | -US$16m |
| Sep 30 2022 | n/a | n/a | -US$16m |
| Jun 30 2022 | n/a | n/a | -US$16m |
| Mar 31 2022 | n/a | n/a | -US$16m |
| Dec 31 2021 | US$1m | US$445k | -US$14m |
| Sep 30 2021 | n/a | n/a | -US$12m |
| Jun 30 2021 | n/a | n/a | -US$9m |
| Mar 31 2021 | n/a | n/a | -US$7m |
| Dec 31 2020 | US$784k | US$435k | -US$7m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$6m |
| Mar 31 2020 | n/a | n/a | -US$6m |
| Dec 31 2019 | US$864k | US$366k | -US$6m |
| Sep 30 2019 | n/a | n/a | -US$5m |
| Jun 30 2019 | n/a | n/a | -US$5m |
| Mar 31 2019 | n/a | n/a | -US$6m |
| Dec 31 2018 | US$515k | US$360k | -US$6m |
| Sep 30 2018 | n/a | n/a | -US$7m |
| Jun 30 2018 | n/a | n/a | -US$7m |
| Mar 31 2018 | n/a | n/a | -US$7m |
| Dec 31 2017 | US$930k | US$55k | -US$7m |
Compensation vs Market: Joe's total compensation ($USD2.00M) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: Joe's compensation has been consistent with company performance over the past year.
CEO
Joe Burnett (46 yo)
6.5yrs
Tenure
US$1,995,337
Compensation
Mr. Joseph Michael Burnett, also known as Joe, has been Chief Executive Officer, President and Director of ClearPoint Neuro, Inc. since November 7, 2017. Mr. Burnett has spent his entire career in medical...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.5yrs | US$2.00m | 0.97% $ 1.4m | |
| Chief Financial Officer | 3.3yrs | US$930.98k | 0.20% $ 291.0k | |
| Chief Business Officer | 1.3yrs | US$838.49k | no data | |
| Chief Operating Officer | 1.6yrs | no data | 0.16% $ 238.3k | |
| General Counsel & Secretary | 3.1yrs | no data | no data | |
| Vice President of Marketing | 4.5yrs | no data | no data |
3.2yrs
Average Tenure
40.5yo
Average Age
Experienced Management: CLPT's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.5yrs | US$2.00m | 0.97% $ 1.4m | |
| Independent Chairman of the Board | 7yrs | US$227.62k | 0.28% $ 406.1k | |
| Independent Director | 4.7yrs | US$189.99k | 0.076% $ 111.1k | |
| Independent Director | 2.8yrs | US$202.49k | 0.047% $ 69.8k | |
| Independent Director | 9.7yrs | US$192.65k | 0.20% $ 298.9k | |
| Independent Director | 2.5yrs | US$182.49k | 0.049% $ 71.3k | |
| Independent Director | 10.2yrs | US$194.75k | 0.16% $ 241.1k | |
| Director | 4.1yrs | US$174.99k | 0.045% $ 66.6k |
5.6yrs
Average Tenure
63yo
Average Age
Experienced Board: CLPT's board of directors are considered experienced (5.6 years average tenure).